Stocks and Investing Stocks and Investing
Fri, October 28, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian White Maintained (AAPL) at Strong Buy and Held Target at $174 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Elyse Greenspan Maintained (ACGL) at Buy with Increased Target to $58 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Dwelle Maintained (ACGL) at Buy with Increased Target to $60 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tracy Benguigui Maintained (ACGL) at Buy with Increased Target to $57 on, Oct 28th, 2022
Thu, October 27, 2022
[ 12:00 AM ] - United States, WOPRAI
Daniel Rich Maintained (AEP) at Hold with Decreased Target to $93 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Faucette Maintained (ADP) at Hold with Increased Target to $250 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Initiated (ACLX) at Strong Buy and Held Target at $31 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brett Linzey Maintained (ZWS) at Strong Buy with Decreased Target to $31 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Silber Maintained (ASGN) at Hold with Decreased Target to $95 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Arren Cyganovich Maintained (ARCC) at Strong Buy with Decreased Target to $21 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Felix Boeschen Maintained (WNC) at Strong Buy with Increased Target to $23 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Joseph Moore Maintained (WOLF) at Hold with Increased Target to $140 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gary Mobley Maintained (WOLF) at Buy with Decreased Target to $110 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ambrish Srivastava Maintained (WOLF) at Hold with Decreased Target to $85 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Toni Kaplan Maintained (WM) at Hold with Decreased Target to $177 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Devin Dodge Maintained (WM) at Hold and Held Target at $164 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Walter Spracklin Maintained (WM) at Hold with Decreased Target to $164 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Nick Setyan Maintained (WING) at Buy with Increased Target to $177 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Joshua Long Maintained (WING) at Buy with Increased Target to $173 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Charles Maintained (WING) at Buy with Increased Target to $165 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Bernstein Maintained (WING) at Buy with Increased Target to $168 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Glass Maintained (WING) at Hold with Increased Target to $140 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jon Tower Maintained (WING) at Strong Buy with Increased Target to $186 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Strelzik Maintained (WING) at Buy with Increased Target to $180 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jared Garber Maintained (WING) at Strong Buy with Increased Target to $160 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eric Sheridan Maintained (AMZN) at Strong Buy and Held Target at $175 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brent Thill Maintained (AMZN) at Strong Buy and Held Target at $165 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steve Chesney Maintained (BMY) at Buy with Decreased Target to $85 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Terence Flynn Maintained (BMY) at Sell with Decreased Target to $60 on, Oct 27th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BMRN) at Buy with Increased Target to $113 on, Oct 27th, 2022

Matthew Harrison Maintained (BMRN) at Buy with Increased Target to $113 on, Oct 27th, 2022


Published on 2024-10-27 23:41:46 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $111 to $113 on, Oct 27th, 2022.

Matthew has made no other calls on BMRN in the last 4 months.



There are 6 other peers that have a rating on BMRN. Out of the 6 peers that are also analyzing BMRN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Luca Issi of "RBC Capital" Maintained at Hold with Increased Target to $95 on, Thursday, October 13th, 2022


These are the ratings of the 5 analyists that currently disagree with Matthew

  • Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $112 on, Monday, October 24th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $128 on, Tuesday, August 9th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $125 on, Thursday, August 4th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Thursday, August 4th, 2022
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $110 on, Wednesday, July 13th, 2022

Contributing Sources